Cetera Investment Advisers Arrowhead Pharmaceuticals, Inc. Transaction History
Cetera Investment Advisers
- $42.2 Billion
- Q2 2024
A detailed history of Cetera Investment Advisers transactions in Arrowhead Pharmaceuticals, Inc. stock. As of the latest transaction made, Cetera Investment Advisers holds 13,982 shares of ARWR stock, worth $307,184. This represents 0.0% of its overall portfolio holdings.
Number of Shares
13,982
Previous 12,370
13.03%
Holding current value
$307,184
Previous $353,000
2.83%
% of portfolio
0.0%
Previous 0.0%
Shares
10 transactions
Others Institutions Holding ARWR
# of Institutions
294Shares Held
91.5MCall Options Held
1.33MPut Options Held
549K-
Black Rock Inc. New York, NY15.7MShares$345 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA12.2MShares$268 Million0.01% of portfolio
-
Avoro Capital Advisors LLC New York, NY8.89MShares$195 Million3.15% of portfolio
-
State Street Corp Boston, MA5.84MShares$128 Million0.01% of portfolio
-
Slate Path Capital LP New York, NY4.14MShares$90.9 Million2.11% of portfolio
About ARROWHEAD PHARMACEUTICALS, INC.
- Ticker ARWR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 105,849,000
- Market Cap $2.33B
- Description
- Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...